More on GLMD
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $43.00 |
|
|||
| Open | $0.62 | ||||
| 52 Wk High | $9.70 | ||||
| 52 Wk Low | $2.78 | ||||
| Day High | $0.62 | ||||
| Day Low | $0.62 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 6,071 | ||||
- Form POS EX Galmed Pharmaceuticals
- Form 424B3 Galmed Pharmaceuticals
- Form 6-K Galmed Pharmaceuticals For: Jun 08
- Galmed to acquire Colospan for $4.5 million in medical device deal
- Galmed Pharmaceuticals to Acquire Colospan to Create a GI-Focused Platform Targeting a $6 Billion Market
- Form 6-K Galmed Pharmaceuticals For: Jun 02
- Galmed and Tissue Dynamics identify cardiac fibrosis pathway
- Tissue Dynamics and Galmed Unveil Unknown Metabolic Pathway for Cardiac Fibrosis and Heart Failure which Supports the Development of Aramchol for Cardiac Fibrosis
- Form 6-K Galmed Pharmaceuticals For: May 14
- Galmed reports 500% bioavailability boost for oral aramchol formulation
Entities mentioned with GLMD
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13G | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Maxim Group | View Related Stories »
- Carl Icahn | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
